Mia Levy, MD, PhD, a practicing oncologist and nationally recognized leader in biomedical informatics, has been appointed director of the Rush University Cancer Center.
A breast cancer specialist who received her medical degree from Rush Medical College, Levy’s leadership and research has helped Vanderbilt-Ingram Cancer Center build data-driven, clinical decision support functionality across the continuum of its cancer care and research efforts. She begins at Rush in January 2019.
She is currently the Ingram Associate Professor of Cancer Research and an associate professor of biomedical informatics and medicine in the School of Medicine at Vanderbilt University. She is also the director of Cancer Health Informatics and Strategy for the Vanderbilt-Ingram Cancer Center, where she helped create the nation’s first web-based precision cancer medicine knowledge resource, My Cancer Genome.
“Dr. Levy has helped shape the field of precision oncology,” said Dr. Larry Goodman, CEO of the Rush system and of Rush University Medical Center. “That leadership and deep understanding of the challenges clinicians face in accessing, interpreting, and applying genomic data will accelerate how Rush’s multi-disciplinary teams devise treatment plans unique to each patient.”
Levy received her undergraduate degree in bioengineering from the University of Pennsylvania in 1997 and her medical degree from Rush Medical College in 2003. She then spent six years at Stanford University Medical Center completing postgraduate training in Internal Medicine and Medical Oncology while completing a doctorate in biomedical informatics.